Lamellar body count

From WikiMD's WELLNESSPEDIA

Lamellar body count is a diagnostic test used primarily in the field of obstetrics and gynecology to assess fetal lung maturity. The test is performed on amniotic fluid obtained through amniocentesis.

Overview[edit]

Lamellar bodies are small organelles found in the cytoplasm of type II pneumocytes in the lungs. They are responsible for the production and storage of pulmonary surfactant, a substance that reduces surface tension in the lungs and prevents alveolar collapse. The number of lamellar bodies in the amniotic fluid can provide an indication of the maturity of the fetal lungs.

Procedure[edit]

The lamellar body count is obtained by centrifuging a sample of amniotic fluid and counting the number of lamellar bodies present using a hematology analyzer. The count is usually expressed as the number of bodies per microliter of fluid.

Interpretation[edit]

A high lamellar body count typically indicates that the fetal lungs are mature and that the baby is likely to be able to breathe independently after birth. A low count suggests that the lungs may not be fully mature, increasing the risk of respiratory distress syndrome if the baby is born prematurely.

Limitations[edit]

While the lamellar body count is a useful tool for assessing fetal lung maturity, it is not infallible. Other factors, such as the presence of blood or meconium in the amniotic fluid, can affect the accuracy of the count. Furthermore, even if the count is high, this does not guarantee that the baby will not experience respiratory problems after birth.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.